Skip to main content

Dave Muoio

By Dave Muoio | 04:15 pm | August 24, 2020
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.            
By Dave Muoio | 12:49 pm | August 24, 2020
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
By Dave Muoio | 03:24 pm | August 21, 2020
Also: Klara closes $15 million for digital patient engagement; Trellus Health collects $5 million seed funding and announces exclusive commercialization deal.
By Dave Muoio | 04:23 pm | August 20, 2020
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
By Dave Muoio | 03:21 pm | August 20, 2020
The patient-facing EASE app is HIPAA compliant, and does not save any texts, photos or videos to the recipient's device.
By Dave Muoio | 12:06 pm | August 20, 2020
The platform recently launched in California, and is eyeing more states down the line.
By Dave Muoio | 03:59 pm | August 19, 2020
The company's diabetic foot ulcer detection platform is now available through 40 VA medical centers.
By Dave Muoio | 02:10 pm | August 19, 2020
Major pharmacies and services say they're unaffected by USPS troubles so far, but some online platforms that rely on the service are worried about their patients and long-term business.
By Dave Muoio | 04:03 pm | August 18, 2020
While the company's new 510(k) cuts down some of the burden, consumers are still advised to consult their healthcare provider before making any changes to their treatments.
By Dave Muoio | 02:35 pm | August 18, 2020
A recent survey suggests that patients value knowledge of how exactly their personal information will be used.